| |
| |
|
| Insider
Information: |
Pellini Michael J |
| Relationship: |
Director |
| City: |
Wayne |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
170,699 |
|
|
Indirect Shares
|
251,933 |
|
|
| Direct
Value |
$580,396 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
422,632 |
|
|
| Total
Value |
$580,396 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -43.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Clarient Inc |
CLRT |
President and COO |
2010-12-22 |
0 |
2008-05-30 |
0 |
Premium* |
|
|
Foundation Medicine, Inc. |
FMI |
Director |
2018-07-31 |
0 |
|
0 |
Premium* |
|
|
Adaptive Biotechnologies Corp |
ADPT |
Director |
2024-03-04 |
54,296 |
2020-10-14 |
0 |
Premium* |
|
|
Singular Genomics Systems, Inc. |
OMIC |
Director |
2022-05-31 |
99,289 |
2022-05-31 |
251,933 |
Premium* |
|
|
GeneDx Holdings Corp |
WGS |
Director |
2022-10-15 |
17,114 |
2022-04-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
73 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FMI |
Foundation Medicine, Inc. |
President & CEOOfficer |
• • – |
2013-09-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
550,000 |
|
- |
|
| OMIC |
Singular Genomics Systems... |
Director |
– • – |
2021-05-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
72,455 |
|
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Director |
– • – |
2021-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,504 |
1,504 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Director |
– • – |
2017-04-03 |
4 |
S |
$31.96 |
$54,332 |
D/D |
(1,700) |
320,933 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
President & CEO |
• • – |
2014-07-02 |
4 |
AS |
$28.00 |
$70,000 |
D/D |
(2,500) |
510,000 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Director |
– • – |
2017-12-07 |
4 |
GD |
$62.25 |
$155,625 |
D/D |
2,500 |
234,728 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Executive Officer |
• • – |
2016-10-04 |
4 |
S |
$23.65 |
$62,176 |
D/D |
(2,629) |
337,270 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Executive Officer |
• • – |
2016-07-05 |
4 |
S |
$18.27 |
$50,042 |
D/D |
(2,739) |
339,899 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
President & CEO |
• • – |
2014-11-14 |
4 |
AS |
$24.84 |
$74,519 |
D/D |
(3,000) |
472,500 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Executive Officer |
• • – |
2017-01-04 |
4 |
S |
$18.49 |
$64,549 |
D/D |
(3,491) |
322,633 |
0 |
- |
|
| CLRT |
Clarient Inc |
President & COO |
• • – |
2008-09-12 |
4 |
B |
$2.09 |
$7,315 |
D/D |
3,500 |
8,500 |
2.81 |
- |
|
| CLRT |
Clarient Inc |
President & COO |
• • – |
2008-09-16 |
4 |
B |
$1.90 |
$6,650 |
D/D |
3,500 |
12,000 |
2.81 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Director |
– • – |
2017-08-09 |
4 |
GD |
$39.15 |
$137,025 |
D/D |
3,500 |
271,577 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Director |
– • – |
2018-03-15 |
4 |
AS |
$78.29 |
$274,015 |
D/D |
(3,500) |
127,870 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Director |
– • – |
2018-04-16 |
4 |
AS |
$74.65 |
$261,275 |
D/D |
(3,500) |
110,711 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Director |
– • – |
2018-05-15 |
4 |
AS |
$76.05 |
$266,175 |
D/D |
(3,500) |
107,211 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Director |
– • – |
2018-06-15 |
4 |
AS |
$105.45 |
$369,075 |
D/D |
(3,500) |
103,711 |
0 |
- |
|
| WGS |
GeneDx Holdings Corp |
Director |
– • – |
2022-10-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,278 |
17,114 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Director |
– • – |
2017-10-02 |
4 |
S |
$38.80 |
$168,741 |
D/D |
(4,349) |
267,228 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
President & CEO |
• • – |
2014-08-15 |
4 |
AS |
$25.61 |
$115,266 |
D/D |
(4,500) |
505,500 |
0 |
- |
|
| CLRT |
Clarient Inc |
President & COO |
• • – |
2008-05-30 |
4 |
B |
$2.00 |
$10,000 |
D/D |
5,000 |
5,000 |
2.81 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
Director |
– • – |
2022-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
6,689 |
8,193 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Executive Officer |
• • – |
2016-07-01 |
4 |
S |
$17.39 |
$129,051 |
D/D |
(7,421) |
342,638 |
0 |
- |
|
| CLRT |
Clarient Inc |
President and COO |
• • – |
2008-11-25 |
4 |
B |
$1.03 |
$8,240 |
D/D |
8,000 |
20,000 |
2.81 |
- |
|
| FMI |
Foundation Medicine, Inc. |
President & CEO |
• • – |
2014-08-18 |
4 |
AS |
$25.10 |
$200,798 |
D/D |
(8,000) |
497,500 |
0 |
- |
|
73 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
